SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-22-005531
Filing Date
2022-02-04
Accepted
2022-02-04 16:36:39
Documents
40

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea154893-s3_inmedpharma.htm S-3 1158344
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP REGARDING LEGALITY OF SECURITIES BEI ea154893ex5-1_inmedpharma.htm EX-5.1 36057
3 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea154893ex23-1_inmedpharma.htm EX-23.1 1990
4 FILING FEE TABLE ea154893ex-fee_inmedpharma.htm EX-FILING FEES 48736
5 GRAPHIC img_001.jpg GRAPHIC 14470
6 GRAPHIC img_002.jpg GRAPHIC 57042
7 GRAPHIC img_003.jpg GRAPHIC 151121
8 GRAPHIC img_004.jpg GRAPHIC 86337
9 GRAPHIC img_005.jpg GRAPHIC 14721
10 GRAPHIC img_006.jpg GRAPHIC 109951
11 GRAPHIC img_007.jpg GRAPHIC 126940
12 GRAPHIC img_008.jpg GRAPHIC 102016
13 GRAPHIC img_009.jpg GRAPHIC 85855
14 GRAPHIC img_010.jpg GRAPHIC 71113
15 GRAPHIC img_011.jpg GRAPHIC 59829
16 GRAPHIC img_012.jpg GRAPHIC 155348
17 GRAPHIC img_013.jpg GRAPHIC 55788
18 GRAPHIC img_014.jpg GRAPHIC 54532
19 GRAPHIC img_015.jpg GRAPHIC 93121
20 GRAPHIC img_016.jpg GRAPHIC 97209
21 GRAPHIC img_017.jpg GRAPHIC 59897
22 GRAPHIC img_018.jpg GRAPHIC 51151
23 GRAPHIC img_019.jpg GRAPHIC 106297
24 GRAPHIC img_020.jpg GRAPHIC 64834
25 GRAPHIC img_021.jpg GRAPHIC 57816
26 GRAPHIC img_022.jpg GRAPHIC 9638
27 GRAPHIC img_023.jpg GRAPHIC 12340
28 GRAPHIC img_024.jpg GRAPHIC 10260
29 GRAPHIC img_025.jpg GRAPHIC 13310
30 GRAPHIC img_026.jpg GRAPHIC 10803
31 GRAPHIC img_027.jpg GRAPHIC 27919
32 GRAPHIC img_028.jpg GRAPHIC 23598
33 GRAPHIC img_029.jpg GRAPHIC 7889
34 GRAPHIC img_030.jpg GRAPHIC 12757
35 GRAPHIC img_031.jpg GRAPHIC 14333
36 GRAPHIC img_032.jpg GRAPHIC 11465
37 GRAPHIC img_033.jpg GRAPHIC 12244
38 GRAPHIC img_034.jpg GRAPHIC 11085
39 GRAPHIC ex5-1_001.jpg GRAPHIC 12984
40 GRAPHIC ex5-1_002.jpg GRAPHIC 10964
  Complete submission text file 0001213900-22-005531.txt   3835745
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-262532 | Film No.: 22593990
SIC: 2834 Pharmaceutical Preparations